human
rhinoviru
rv
positivestrand
rnaviru
famili
picornavirida
genu
enteroviru
three
speci
found
b
c
develop
highli
sensit
molecular
techniqu
rv
wide
known
major
caus
common
cold
upper
respiratori
ill
also
proven
caus
lower
respiratori
diseas
evid
contributor
asthma
induct
exacerb
especi
rva
rvc
seem
caus
sever
respiratori
ill
domin
rvb
patient
asthma
chronic
obstruct
pulmonari
diseas
moreov
rva
rvc
common
hospit
children
rv
infect
caus
cell
destruct
chang
immunolog
reaction
influenc
express
sever
interferon
cytokin
il
interleukin
ifn
interferon
differ
immun
respons
three
speci
extens
studi
jong
et
al
found
signific
differ
cytokin
level
nasopharyng
aspir
rvinfect
children
studi
four
cytokin
tumor
necrosi
factor
seem
rvb
replic
slowli
induc
less
cytokin
product
rva
rvc
previou
studi
regard
tonsil
good
investig
immun
respons
tonsil
local
lymphoid
tissu
close
contact
infect
agent
allergen
studi
aim
observ
differ
tonsillar
cytokin
express
rva
b
c
speci
routin
tonsillectomi
patient
previou
studi
concern
cytokin
express
nasopharyng
aspir
hospit
patient
enrol
patient
go
elect
tonsillectomi
adenotomi
april
march
due
clinic
indic
oper
satakunta
central
hospit
pori
finland
written
consent
particip
studi
patient
hisher
guardian
consid
inclus
criteria
along
tonsillectomi
studi
protocol
approv
ethic
committe
satakunta
central
hospit
enrol
patient
collect
sampl
tonsil
nasopharyng
aspir
peripher
blood
tonsillectomi
perform
accord
clinic
routin
tonsil
sampl
cut
mm
piec
store
rnalat
rna
stabil
reagent
qiagen
hilden
germani
incub
next
work
day
remov
nonabsorb
reagent
store
nasopharyng
aspir
collect
begin
oper
anesthesia
use
standard
procedur
viral
analysi
part
tonsil
nasopharyng
aspir
np
store
dri
tube
serum
oh
measur
serum
ige
measur
food
allergen
aeroallergen
screen
phadiatop
phadia
uppsala
sweden
made
peripher
blood
sampl
patient
hisher
guardian
also
fill
standard
questionnair
concern
respiratori
symptom
day
prior
oper
allerg
diseas
addit
file
tabl
inhous
realtim
pcr
use
detect
enteroviru
ev
human
respiratori
syncyti
viru
rsv
rv
detect
adenoviru
adv
coronaviru
cov
influenza
b
virus
flu
b
metapneumoviru
mpv
parainfluenza
viru
type
piv
rsv
group
b
rv
seeplex
ace
detect
multiplex
pcr
assay
use
seegen
seoul
korea
viru
diagnost
perform
depart
virolog
univers
turku
turku
finland
depart
clinic
microbiolog
karolinska
univers
hospit
stockholm
sweden
rhinoviru
type
made
amplifi
sequenc
partial
non
code
region
rv
genom
previous
stabil
tonsil
tissu
homogen
grind
tube
contain
ceram
bead
use
precelli
homogen
bertin
technolog
montigni
le
bretonneux
franc
two
time
rpm
total
rna
isol
use
rneasi
mini
kit
qiagen
hilden
germani
revers
transcript
perform
revert
aid
mmulv
revers
transcriptas
fermenta
st
leonrot
germani
use
random
hexam
primer
accord
manufactur
protocol
gene
express
tumour
growth
factor
forkhead
box
protein
gatabind
factor
rarrel
orphan
receptor
c
tbet
tbox
transcript
factor
analyz
quantit
realtim
pcr
use
itaq
sybr
green
supermix
rox
biorad
hercul
ca
usa
fast
realtim
pcr
instrument
appli
biosystem
foster
citi
ca
usa
housekeep
elong
factor
use
normal
data
shown
rel
express
show
valu
multipli
correspond
differ
ct
valu
gene
interest
data
analyz
use
jmp
pro
version
softwar
sa
institut
inc
cari
nc
usa
due
skew
distribut
continu
variabl
describ
median
interquartil
rang
analyz
use
test
categor
variabl
express
frequenc
percentag
analyz
use
chi
squar
test
exact
test
count
regress
analys
cytokin
transcript
factor
valu
logtransform
posit
skew
distribut
clinic
viral
immunolog
differ
studi
group
analyz
use
unadjust
multivari
linear
model
analysi
adjust
immunolog
analys
includ
clinic
factor
viru
infect
significantli
differ
group
sex
season
surgeri
spring
fall
respiratori
symptom
oper
day
rhiniti
oper
day
age
backward
stepwis
method
use
final
adjust
model
separ
cytokin
transcript
factor
statist
signific
factor
kept
model
p
consid
statist
signific
patient
viral
immunolog
analyz
made
tonsil
fiftyseven
patient
exclud
poor
qualiti
tonsil
sampl
fig
patient
fiftyseven
sampl
rhinoviru
posit
primari
pcr
test
rhinoviru
sequenc
success
sampl
fig
median
age
studi
subject
year
male
food
aeroallergen
sensit
tabl
main
indic
tonsillectomi
tonsillar
hypertrophi
subject
recurr
infect
tonsil
subject
tabl
rva
c
group
male
domin
rva
epidem
occur
spring
rvc
epidem
fall
rva
infect
subject
often
symptomat
tabl
sixteen
patient
posit
rva
posit
rvb
posit
rvc
detect
np
tabl
common
viru
codetect
adv
cov
np
adv
ev
piv
tonsil
tabl
codetect
np
ev
flu
b
piv
rsv
tonsil
cov
mpv
rsv
tonsil
rv
found
one
patient
group
statist
signific
differ
viru
codetect
rv
speci
tabl
tabl
present
express
rate
cytokin
transcript
factor
includ
tregulatori
type
cytokin
transcript
factor
type
iiii
interferon
adjust
analysi
highest
express
lowest
express
associ
rvc
detect
p
overal
differ
fig
rvb
detect
associ
lowest
tbet
express
p
overal
differ
fig
otherwis
signific
differ
tendenc
found
tabl
clinic
consequ
rhinoviru
b
c
infect
previous
proven
differ
thu
evid
immunolog
respons
due
distinct
speci
divers
bear
thing
mind
conduct
studi
routin
tonsillectomi
patient
three
main
find
first
rhinoviru
speci
b
c
rather
equal
distribut
among
rel
asymptomat
tonsillectomi
patient
mainli
found
nasopharyng
aspir
compar
low
persist
rate
tonsil
second
rhinoviru
speci
differ
associ
tonsillar
cytokin
respons
rhinoviru
c
affect
patient
increas
decreas
express
tonsil
compar
rhinoviru
speci
fig
third
rhinoviru
speci
differ
associ
clinic
characterist
similar
incid
rate
rv
speci
bit
unexpect
sinc
rvb
usual
slightli
less
preval
rva
rvc
healthi
subject
howev
differ
pronounc
children
sever
wheez
asthma
rva
rvc
speci
also
associ
sever
symptom
children
studi
subject
rather
young
median
year
old
gener
healthi
like
favor
equal
distribut
rv
speci
symptomat
asymptomat
infect
also
common
children
adult
found
differ
rhinoviru
b
c
posit
tonsillectomi
patient
term
viral
coinfect
shown
viral
codetect
common
especi
children
morikawa
et
al
note
coinfect
rate
rva
c
high
remain
unclear
whether
found
differ
coinfect
rate
rva
rvb
rvc
miller
et
al
found
coinfect
rva
rvc
hospit
children
found
male
sex
domin
rva
rvc
infect
patient
line
previou
studi
male
sex
domin
rva
rvc
infect
hospit
children
reason
might
sex
hormon
androgen
promot
helper
type
cell
respons
estrogen
progesteron
respons
season
rhinoviru
type
seem
follow
season
describ
literatur
major
peak
fall
smaller
peak
spring
rhinovirus
detect
throughout
whole
year
rvc
rvb
found
mostli
patient
oper
fall
wherea
rva
commonli
found
spring
interest
novel
find
higher
level
tonsillar
product
patient
rva
rvc
infect
especi
rvc
compar
rvb
infect
patient
type
interferon
includ
import
antivir
cytokin
prevent
inappropri
respons
consid
abil
rva
rvc
caus
sever
infect
rvb
plausibl
may
also
induc
stronger
interferon
respons
fact
strong
respons
associ
reduc
viru
shed
exposur
limit
rv
infect
vitro
find
agreement
previou
find
extend
increas
express
type
interferon
local
lymphoid
tissu
level
healthi
individu
moreov
previou
find
suggest
rvc
may
caus
slightli
sever
infect
rva
also
fit
find
addit
found
close
signific
differ
tbet
express
tonsil
patient
harbor
distinct
rv
speci
fig
level
express
highest
patient
rva
infect
lowest
rvb
infect
tbet
control
different
cell
act
togeth
runtrel
transcript
factor
induc
product
glanvil
et
al
found
tbet
defici
mice
develop
respons
rv
infect
instead
respons
also
found
tbet
defici
mice
develop
signific
eosinophilia
mucu
product
rv
infect
find
tbet
agreement
previou
experiment
clinic
data
higher
tbet
express
support
also
declin
rvc
group
also
agreement
find
glanvil
et
al
act
transcript
factor
involv
mani
inflammatori
disord
rate
respiratori
symptom
oper
day
fairli
small
thu
patient
repres
mostli
asymptomat
subject
half
symptom
week
prior
oper
might
reflect
viru
shed
past
symptomat
infect
may
take
even
week
rhinoviru
disappear
nasal
mucu
even
healthi
children
rhinoviru
found
asymptomat
individu
give
explan
small
proport
rhinoviru
infect
patient
symptom
oper
day
major
patient
respiratori
symptom
oper
day
rva
rvc
infect
one
rvb
infect
support
stronger
clinic
import
rva
rvc
strength
studi
consist
rel
healthi
tonsillectomi
patient
therebi
result
suggest
normal
cytokin
respons
due
symptomat
asymptomat
rv
infect
mani
previou
studi
concern
hospit
patient
acut
infect
also
studi
popul
construct
children
adult
wherea
often
studi
concern
children
also
use
singl
cytokin
pcr
patient
well
preced
symptom
wellcharacter
also
limit
sampl
size
rel
small
subpopul
studi
subject
studi
power
detect
signific
chang
outcom
measur
studi
virus
bacteria
control
group
observ
clearli
associ
presenc
acut
infect
result
gener
healthi
individu
immun
respons
due
rvinfect
dynam
process
relev
histori
previou
rv
infect
remain
obscur
sampl
taken
singl
time
point
tonsil
remov
therefor
difficult
assess
whether
observ
chang
timedepend
uniform
longer
period
time
best
knowledg
first
time
studi
immun
respons
rhinoviru
speci
local
lymphoid
tissu
level
found
rhinoviru
speci
associ
differ
clinic
characterist
tonsillar
cytokin
respons
interest
find
increas
tbet
decreas
rhinoviru
c
affect
patient
suggest
rhinoviru
c
infect
greater
effect
tonsillar
respons
rhinoviru
b
infect
result
encourag
studi
immun
respons
local
lymphoid
tissu
level
use
tonsil
